Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Arielle Janine Medford, M.D.


2020 - 2021
Chief Resident - Massachusetts General Hospital - Internal Medicine
Senior Resident Teaching Award - Massachusetts General Hospital
Humanism in Medicine Award - Massachusetts General Hospital
Resident Teaching Award - Harvard Medicine School

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Medford AJ, Oshry L, Boyraz B, Kiedrowski L, Menshikova S, Butusova A, Dai CS, Gogakos T, Keenan JC, Occhiogrosso RH, Ryan P, Lennerz JK, Spring LM, Moy B, Ellisen LW, Bardia A. TRK inhibitor in a patient with metastatic triple-negative breast cancer and NTRK fusions identified via cell-free DNA analysis. Ther Adv Med Oncol. 2023; 15:17588359231152844. PMID: 36743521; PMCID: PMC9893401.
  2. Davis AA, Gerratana L, Clifton K, Medford AJ, Velimirovic M, Hensing WL, Bucheit L, Shah AN, D'Amico P, Reduzzi C, Zhang Q, Dai CS, Denault EN, Bagegni NA, Opyrchal M, Ademuyiwa FO, Bose R, Gradishar WJ, Behdad A, Ma CX, Bardia A, Cristofanilli M. Circulating tumour DNA characterisation of invasive lobular carcinoma in patients with metastatic breast cancer. EBioMedicine. 2022 Dec; 86:104316. PMID: 36332363; PMCID: PMC9637866.
    Citations:    Fields:    Translation:Humans
  3. Abelman RO, Medford A, Spring L, Bardia A. Antibody-Drug Conjugates in Breast Cancer: Spotlight on HER2. Cancer J. 2022 Nov-Dec 01; 28(6):423-428. PMID: 36383904; PMCID: PMC9681022.
    Citations:    Fields:    Translation:Humans
  4. Medford A, Spring LM, Moy B, Bardia A. Antibody drug conjugates for patients with breast cancer. Curr Probl Cancer. 2021 10; 45(5):100795. PMID: 34635342.
    Citations: 1     Fields:    Translation:Humans
  5. Yeku OO, Medford AJ, Fenves AZ, Uljon SN. Case 15-2021: A 76-Year-Old Woman with Nausea, Diarrhea, and Acute Kidney Failure. N Engl J Med. 2021 May 20; 384(20):1943-1950. PMID: 34010534.
    Citations:    Fields:    Translation:Humans
  6. Velimirovic M, Juric D, Niemierko A, Spring L, Vidula N, Wander SA, Medford A, Parikh A, Malvarosa G, Yuen M, Corcoran R, Moy B, Isakoff SJ, Ellisen LW, Iafrate A, Chabner B, Bardia A. Rising Circulating Tumor DNA As a Molecular Biomarker of Early Disease Progression in Metastatic Breast Cancer. JCO Precis Oncol. 2020 Nov; 4:1246-1262. PMID: 35050782.
    Citations: 3     Fields:    
  7. Velimirovic, M., Juric, D., Niemierko, A., Spring, L., Vidula, N., Wander, S. A., Medford, A., Parikh, A., Malvarosa, G., Yuen, M., Corcoran, R., Moy, B., Isakoff, S. J., Ellisen, L. W., Iafrate, A., Chabner, B., & Bardia, A. Rising Circulating Tumor DNA As a Molecular Biomarker of Early Disease Progression in Metastatic Breast Cancer. JCO Precision Oncology. 2020; 4:1246–1262.
  8. Dalton WB, Helmenstine E, Walsh N, Gondek LP, Kelkar DS, Read A, Natrajan R, Christenson ES, Roman B, Das S, Zhao L, Leone RD, Shinn D, Groginski T, Madugundu AK, Patil A, Zabransky DJ, Medford A, Lee J, Cole AJ, Rosen M, Thakar M, Ambinder A, Donaldson J, DeZern AE, Cravero K, Chu D, Madero-Marroquin R, Pandey A, Hurley PJ, Lauring J, Park BH. Hotspot SF3B1 mutations induce metabolic reprogramming and vulnerability to serine deprivation. J Clin Invest. 2019 08 08; 129(11):4708-4723. PMID: 31393856; PMCID: PMC6819102.
    Citations: 16     Fields:    Translation:HumansAnimalsCells
  9. Medford AJ, Dubash TD, Juric D, Spring L, Niemierko A, Vidula N, Peppercorn J, Isakoff S, Reeves BA, LiCausi JA, Wesley B, Malvarosa G, Yuen M, Wittner BS, Lawrence MS, Iafrate AJ, Ellisen L, Moy B, Toner M, Maheswaran S, Haber DA, Bardia A. Blood-based monitoring identifies acquired and targetable driver HER2 mutations in endocrine-resistant metastatic breast cancer. NPJ Precis Oncol. 2019; 3:18. PMID: 31341951; PMCID: PMC6635494.
    Citations: 10     
  10. Medford A, Brunner A, Nardi V, Hasserjian R, Carlson J, Choy E. Therapy-Related Erythroleukemia in a Man With Metastatic Ewing Sarcoma: A Clinical Role for Advanced Molecular Diagnostics. JCO Precis Oncol. 2018 Nov; 2:1-6. PMID: 35135116.
    Citations:    Fields:    
  11. Cravero K, Medford A, Pallavajjala A, Canzoniero J, Hunter N, Chu D, Cochran RL, Waters I, Christenson ES, Kyker-Snowman K, Button B, Cole AJ, Park BH. Biotinylated amplicon sequencing: A method for preserving DNA samples of limited quantity. Pract Lab Med. 2018 Nov; 12:e00108. PMID: 30140723; PMCID: PMC6104457.
  12. Medford A, Brunner A, Nardi V, Hasserjian R, Carlson J, Choy E. Therapy-Related Erythroleukemia in a Man With Metastatic Ewing Sarcoma: A Clinical Role for Advanced Molecular Diagnostics. JCO Precision Oncology. 2018; (2):1-6. View Publication.
  13. Medford AJ, Gillani RN, Park BH. Detection of Cancer DNA in Early Stage and Metastatic Breast Cancer Patients. Methods Mol Biol. 2018; 1768:209-227. PMID: 29717446.
    Citations: 6     Fields:    Translation:Humans
  14. Cidado J, Wong HY, Rosen DM, Cimino-Mathews A, Garay JP, Fessler AG, Rasheed ZA, Hicks J, Cochran RL, Croessmann S, Zabransky DJ, Mohseni M, Beaver JA, Chu D, Cravero K, Christenson ES, Medford A, Mattox A, De Marzo AM, Argani P, Chawla A, Hurley PJ, Lauring J, Park BH. Ki-67 is required for maintenance of cancer stem cells but not cell proliferation. Oncotarget. 2016 Feb 02; 7(5):6281-93. PMID: 26823390.
    Citations: 35     Fields:    Translation:HumansCells
  15. Chu D, Paoletti C, Gersch C, VanDenBerg DA, Zabransky DJ, Cochran RL, Wong HY, Toro PV, Cidado J, Croessmann S, Erlanger B, Cravero K, Kyker-Snowman K, Button B, Parsons HA, Dalton WB, Gillani R, Medford A, Aung K, Tokudome N, Chinnaiyan AM, Schott A, Robinson D, Jacks KS, Lauring J, Hurley PJ, Hayes DF, Rae JM, Park BH. ESR1 Mutations in Circulating Plasma Tumor DNA from Metastatic Breast Cancer Patients. Clin Cancer Res. 2016 Feb 15; 22(4):993-9. PMID: 26261103.
    Citations: 75     Fields:    Translation:Humans
  16. Patel SR, Cadwell CM, Medford A, Zimring JC. Transfusion of minor histocompatibility antigen-mismatched platelets induces rejection of bone marrow transplants in mice. J Clin Invest. 2009 Sep; 119(9):2787-94. PMID: 19726874; PMCID: PMC2735899.
    Citations: 20     Fields:    Translation:HumansAnimalsCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Medford's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (70)
Co-Authors (33)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.